Last reviewed · How we verify
NCT04549675
Couple-focused Intervention for Sun Protection
Phase 3 trial testing Sun Safe Partners Online in Skin Cancer Prevention in 150 participants. Completed in 30 November 2020.
30 November 2019
Quick facts
| Lead sponsor | Rutgers, The State University of New Jersey |
|---|---|
| Phase | Phase 3 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 150 |
| Start date | 1 May 2019 |
| Primary completion | 30 November 2019 |
| Estimated completion | 30 November 2020 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Sun Safe Partners Online
- Generic Online Sun Safety Information intervention
Conditions studied
- Skin Cancer Prevention — all drugs for Skin Cancer Prevention →
Sponsor
Rutgers, The State University of New Jersey
Who can join
Adults 18 to 75, any sex, with Skin Cancer Prevention. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this pilot study is to develop and test a couple-based intervention to increase sun protection practices. First, the investigators will develop the intervention website, Sun Safe Partners online. Next, the investigators will gather feedback and preferences for content in a small sample of couples who do not regularly engage in sun protection practices. The investigators will also gather preliminary information regarding the impact of the couple-based intervention.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Sun Safe Partners Online: Pilot Randomized Controlled Clinical Trial.
Manne S, Buller D, Devine K, Heckman C, et al · · 2020 · cited 5× · PMID 32673215 · DOI 10.2196/18037
Verify or expand the search:
- PubMed search for NCT04549675
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Rutgers, The State University of New Jersey trials
Trials by the same sponsor.
- NCT07243886 — Mobile-based Obstetric Monitoring for Pregnancies Complicated by Hypertension and/or Diabetes (MOM-HD) · NA · not yet recruiting
- NCT06955130 — Lactate and Glycerol Contribution to Gluconeogenesis · NA · not yet recruiting
- NCT06822010 — SeqUential GeMcitabine and MITomycin Treatment for Favorable High-Risk Upper Urinary Tract Urothelial Carcinoma · Phase 2 · not yet recruiting
- NCT07525011 — Comparative Study of Denture Fabrication Techniques · NA · not yet recruiting
- NCT06834204 — Advancing Care Coordination Between Cancer and Primary Care Teams for Complex Cancer Survivors · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04549675 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Rutgers, The State University of New Jersey
- Last refreshed: 8 April 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04549675.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing